You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bosulif

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dementia With Lewy Bodies Trial in Washington (Placebo Oral Tablet, Bosutinib Oral Tablet)

Completed
  • Dementia With Lewy Bodies
  • Placebo Oral Tablet
  • Bosutinib Oral Tablet
  • Washington, District of Columbia
    MedStar Georgetown University Hospital
Apr 4, 2022

Describe Real World Use of Bosutinib inSingle Centre in Scotland

Completed
  • Myeloid Leukemia
  • Glasgow, United Kingdom
    eatson West of Scotland Cancer Centre
May 3, 2022

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

Chronic Phase-Chronic Myeloid Leukemia Trial in Madrid (Bosutinib 400 MG Monotherapy, Bosutinib 400 MG + Atezolizumab 840 MG in

Recruiting
  • Chronic Phase-Chronic Myeloid Leukemia
  • Bosutinib 400 MG Monotherapy
  • Bosutinib 400 MG + Atezolizumab 840 MG in 14 ML Injection
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Mar 8, 2021

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial

Recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
  • Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
  • Houston, Texas
  • +3 more
Jan 25, 2022

Safety And Efficacy Of Bosutinib

Recruiting
  • Chronic Myelogenous Leukemia
  • Shibuya-ku, Japan
    (unnamed)
Dec 29, 2020

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Recurrent Acute Myeloid Leukemia Trial in Duarte (Bosutinib Monohydrate, Decitabine, Enasidenib Mesylate)

Withdrawn
  • Recurrent Acute Myeloid Leukemia
  • Bosutinib Monohydrate
  • +6 more
  • Duarte, California
    City of Hope Meidcal Center
Jun 7, 2022

Mild Cognitive Impairment, Dementia Trial in Santa Monica (bosutinib)

Enrolling by invitation
  • Mild Cognitive Impairment
  • Dementia
  • Santa Monica, California
    Neurological Associates of West LA
Feb 25, 2021

The Life After Stopping Tyrosine Kinase Inhibitors Study

Completed
  • Leukemia, Myeloid, Chronic
  • Imatinib (Stopping their TKI)
  • +3 more
  • San Francisco, California
  • +15 more
Jan 3, 2023

Leukemia, Myelogenous, Chronic Trial in Monza, Milano (Bosutinib, Bone Marrow Transplant, Bone Marrow cells)

Completed
  • Leukemia
  • +3 more
  • Monza, Italy/MB, Italy
  • +1 more
Nov 3, 2020

Previously Treated PH + CML Trial in Worldwide (Bosutinib)

Terminated
Has Results
  • Previously Treated PH + CML
  • Los Angeles, California
  • +47 more
Dec 2, 2021

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Blasts Under 15 Percent of Bone Marrow Nucleated Cells, Blasts Under 15 Percent of Peripheral Blood White Cells, Blasts Under 30

Terminated
Has Results
  • Blasts Under 15 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2020

Describe The Real World Use Of Bosutinib In The UK And

Completed
Has Results
  • Chronic Myeloid Leukaemia
  • Liverpool, Merseyside, United Kingdom
  • +2 more
May 1, 2019

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Trial in Worldwide

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
  • Anaheim, California
  • +188 more
Apr 16, 2021

Chronic Myelogenous Leukaemia Trial in Bonn (Bosulif)

Unknown status
  • Chronic Myelogenous Leukaemia
  • Bosulif
  • Bonn, Germany
    University Hospital Bonn
Jun 28, 2017